Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0545120080180121945
Journal of Microbiology and Biotechnology
2008 Volume.18 No. 12 p.1945 ~ p.1952
Enhanced Sialylation of Recombinant Erythropoietin in CHO Cells by Human Glycosyltransferase Expression
Jeong Yeon-Tae

Choi One
Lim Hye-Rim
Son Young-Dok
Kim Hong-Jin
Kim Jung-Hoe
Abstract
Sialylation, the attachment of sialic acid residues to a protein, can affect the biological activity and in vivo circulatory half-life of glycoproteins. Human ¥á2,3- sialyltransferase (¥á2,3-ST) and ¥â1,4-galactosyltransferase (¥â1,4-GT) are responsible for terminal sialylation and galactosylation, respectively. Enhanced sialylation of human erythropoietin (EPO) by the expression of ¥á2,3-ST and ¥â1,4-GT was achieved using recombinant Chinese hamster ovary (CHO) cells (EC1). The sialic acid content and sialylation of N-glycans were evaluated by HPLC. When ¥á2,3-ST was expressed in CHO cells (EC1-ST2), the sialic acid content (moles of sialic acid/mole of EPO) increased from 6.7 to 7.5. In addition, the amount of trisialylated glycans increased from 17.3% to 26.1%. When ¥á2,3-ST and ¥â1,4-GT were coexpressed in CHO cells (EC1-GTST15), the degree of sialylation was greater than that in EC1-ST2 cells. In the case of EC1-GTST15 cells, the sialic acid content increased to 8.2 and the proportion of trisialylated glycans was markedly increased from 17.3% to 35.5%. Interestingly, the amount of asialoglycans decreased only in the case of GTST15 cells (21.4% to 14.2%). These results show that coexpression of ¥á2,3- ST and ¥â1,4-GT is more effective than the expression of ¥á2,3-ST alone. Coexpression of ¥á2,3-ST and ¥â1,4-GT did not affect CHO cell growth and metabolism or EPO production. Thus, coexpression of ¥á2,3-ST and ¥â1,4-GT may be beneficial for producing therapeutic glycoproteins with enhanced sialylation in CHO cells.
KEYWORD
Glycosylation, sialylation, recombinant erythropoietin, sialyltransferase, galactosyltransferase
FullTexts / Linksout information
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI)